1. Introduction {#sec1}
===============

Degenerative aortic stenosis (AS), the most common valvular heart disease in the elderly, has become a leading cause for surgical valve replacement in industrialized countries. As a result of rising life expectancy and ageing populations, the global prevalence of AS is increasing and is expected to surpass 10 billion by 2100 \[[@B1]--[@B3]\].

Degenerative AS has long been considered a chronic process with gradual deposition of calcium phosphate in the valve occurring with age. However, emerging evidence has indicated that this condition is mediated by the interplay of complex biological processes that include the following: inflammation, cell apoptosis, lipids deposition, renin-angiotensin system activation, remodeling of the extracellular matrix, and bone formation \[[@B4]--[@B11]\]. However, the underlying mechanisms that regulate this process remain largely unknown \[[@B12], [@B13]\].

MicroRNAs (miRNAs) are small, 21--25-nucleotide, endogenous, single-stranded noncoding RNAs that regulate target gene expression by binding messenger RNAs (mRNAs) and inhibiting or reducing translation. A single miRNA can regulate numerous genes, while a single gene can be regulated by multiple miRNAs \[[@B14]\]. miRNAs play a critical role in many physiological processes, and there is a growing body of studies indicating that distinct patterns of altered miRNA expression are associated with specific disease processes \[[@B15]--[@B19]\]. In the present study, we explore the miRNA expression signature of degenerative AS to improve our understanding of the molecular alternations in this disease.

2. Methods {#sec2}
==========

2.1. Tissue Samples Collection and RNA Isolation {#sec2.1}
------------------------------------------------

Written informed consent was obtained from all participants of age and/or via their parents. All procedures in this study were approved by the Ethics Committees of the First Affiliated Hospital of Nanjing Medical University and conformed to the principles outlined in the Declaration of Helsinki. Tissue samples from four healthy controls were obtained from prospective multiorgan donors without cardiovascular pathology in cases in which technical reasons prevented transplantation. Aortic valves from patients with degenerative AS were obtained from four patients who underwent surgical valve replacement. General characteristics of these participants are displayed in [Table 1](#tab1){ref-type="table"}. Gross and histological examination was performed to confirm the presence/absence of AS in each sample. Valve samples were immediately snap-frozen in liquid nitrogen upon collection. Total RNA was extracted using an RNeasy Mini Kit in accordance with the manufacturer\'s protocol (Qiagen, Hilden, Germany).

2.2. RNA Labeling and Array Hybridization {#sec2.2}
-----------------------------------------

miRNA expression was evaluated using Agilent miRNA arrays (V2), which included 723 human and 76 human viral miRNAs from the Sanger database v.10.1 (Agilent Technologies, Foster City, CA). Total RNA was dephosphorylated and ligated with pCp-Cy3 and subsequently hybridized to the arrays. After samples were washed and scanned, using Agilent Scan Control software, the Agilent Feature Extract software v9.5.3 was used to analyze the arrays. Each sample was evaluated in triplicate. miRNA expression data were normalized using a bead-based assay and the locally weighted smooth spline (LOWESS) method. After normalization, all expression values were transformed to a linear scale for statistical analysis.

2.3. Bioinformatic Analysis {#sec2.3}
---------------------------

GeneSpring 13.1 was used to identify potential human miRNA target genes, which compared TargetScan, PITA, and microRNAorg databases and created a Venn diagram to demonstrate relations among the databases. Gene Ontology (GO) analysis was performed to investigate the biological processes, cellular components, and specific molecular function of differentially expressed coding genes identified. Pathway analysis was used to determine the involvement of coexpressed genes in different biological pathways according to Kyoto Encyclopedia of Genes and Genomes (KEGG).

2.4. Statistical Analysis {#sec2.4}
-------------------------

Independent Student\'s *t*-test was used to determine whether there were any significant differences between the miRNA expression profiles between two groups. *p* values less than 0.05 (*p* \< 0.05) were considered to be statistically significant. Significant data were further analyzed by cluster analysis, and the expression profiles were visualized with GeneSpring 10.0 (Agilent Technologies).

3. Results {#sec3}
==========

3.1. Unsupervised Hierarchical Cluster Analysis of miRNA Microarray Data {#sec3.1}
------------------------------------------------------------------------

miRNA microarray identified 20 miRNAs with significantly differential expression (\>2.0-fold) in AS samples relative to normal controls. Six miRNAs were overexpressed (hsa-miR-193a-3p, hsa-miR-29b-1-5p, hsa-miR-505-5p, hsa-miR-194-5p, hsa-miR-99b-3p, and hsa-miR-200b-3p) and 14 (hsa-miR-3663-3p, hsa-miR-513a-5p, hsa-miR-146b-5p, hsa-miR-1972, hsa-miR-718, hsa-miR-3138, hsa-miR-21-5p, hsa-miR-630, hsa-miR-575, hsa-miR-301a-3p, hsa-miR-636, hsa-miR-34a-3p, hsa-miR-21-3p, and hsa-miR-516a-5p) were downregulated in aortic tissue from AS patients ([Table 2](#tab2){ref-type="table"}). Unsupervised hierarchic clustering was performed based on the 20 differentially expressed miRNAs and displayed as heat map ([Figure 1](#fig1){ref-type="fig"}).

microRNAorg, TargetScan, and PITA were used to predict the targets of differentially expressed miRNAs in CAVD samples using software GeneSpring 13.1. A Venn diagram was generated to highlight the relations among the 3 databases. There are 1010 overlapping genes identified by all 3 programs, which are most likely to be targets of miRNAs in patients with AS ([Figure 2](#fig2){ref-type="fig"}).

3.2. GO and Pathway Analysis {#sec3.2}
----------------------------

Gene Ontology (<http://geneontology.org/>) was used to classify the function of up- and downregulated genes from 3 structured networks: biological processes, cellular components, and molecular function.

In this study, differentially expressed mRNAs were enriched in numerous biological processes including the following: cell adhesion, homophilic cell adhesion, positive regulation of transcription, negative regulation of JAK-STAT cascade, and positive regulation of G1/S transition of mitotic cell cycle associated with biological processes ([Figure 3(a)](#fig3){ref-type="fig"}). Similarly, the following cellular components were affected: nucleus, nucleoplasm, and cytoplasm linked with cellular components ([Figure 3(b)](#fig3){ref-type="fig"}), while affected molecular functions include the following: protein binding, zinc ion binding, and transcriptional activator activity involved in molecular functions ([Figure 3(c)](#fig3){ref-type="fig"}). Moreover, KEGG pathway analysis identified significantly (*p* \< 0.05) affected pathways including the following: cAMP signaling pathway, vascular smooth muscle contraction, regulation of actin cytoskeleton, neurotrophin signaling pathway, and cGMP-PKG signaling pathway ([Figure 4](#fig4){ref-type="fig"}).

4. Discussion {#sec4}
=============

Recent studies have improved our understanding of the mechanisms underlying AS \[[@B12], [@B20]\]. However, there are not many reports that have investigated the function of miRNAs as they relate to the pathobiology of AS \[[@B21]--[@B26]\].

A microRNA expression signature provides a better understanding of the mechanisms of a disease \[[@B27]\]. In the present study, we explored miRNA expression signatures associated with degenerative AS using miRNA microarray analysis. Six overexpressed miRNAs (hsa-miR-193a-3p, hsa-miR-29b-1-5p, hsa-miR-505-5p, hsa-miR-194-5p, hsa-miR-99b-3p, and hsa-miR-200b-3p) and 14 downregulated miRNAs (hsa-miR-3663-3p, hsa-miR-513a-5p, hsa-miR-146b-5p, hsa-miR-1972, hsa-miR-718, hsa-miR-3138, hsa-miR-21-5p, hsa-miR-630, hsa-miR-575, hsa-miR-301a-3p, hsa-miR-636, hsa-miR-34a-3p, hsa-miR-21-3p, and hsa-miR-516a-5p) were identified in patients with AS, relative to normal controls, and their general characteristics and functional annotations were analyzed using bioinformatic tools.

There were other miRNA microarrays performed about AS before, and, in these studies, the main cause of AS is calcification of the aortic valves \[[@B20], [@B22]\]. However, as rheumatic fever remains to be the most important etiological factor in calcific aortic valve disease (CAVD) in China, we do not choose CAVD patients to reduce confounding factors when exploring the mechanisms that underlie degenerative AS.

As a limitation of our study, the specific pathways affected by miRNAs and which cause AS remain elusive. Further studies are required to functionally characterize the role of specific candidate miRNAs.

In conclusion, the present study improved our understanding of the role of miRNAs in degenerative AS. Our findings provide improved understanding of the molecular alterations in this disease and may provide potential targets for future clinical applications.
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![Unsupervised hierarchical clustering identified two distinct groups (control versus AS) based on their miRNA expression profile. Sample names are listed at the top. The names of the significantly (*p* \< 0.05) differentially expressed miRNAs are shown on the right. Twenty miRNAs were expressed differently in target genes analysis.](BMRI2016-4682172.001){#fig1}

![The red, green, and blue sets stand for target genes predicted by databases microRNAorg, TargetScan, and PITA, respectively.](BMRI2016-4682172.002){#fig2}

![GO analysis for differentially expressed mRNAs. (a)--(c) GO analysis according to biological process, cellular component, and molecular function, respectively, ranked by enrichment score (−log~10~ (*p* value)).](BMRI2016-4682172.003){#fig3}

![Pathway analysis based on the KEGG database. Ranked by enrichment score (−log~10~ (*p* value)).](BMRI2016-4682172.004){#fig4}

###### 

Characteristics of the participants.

                      Control       AS           *p* value
  ------------------- ------------- ------------ -----------
  Number              4             4            ns
  Male                4             4            ns
  Age                 41.5 ± 10.4   58.3 ± 4.6   0.0429
  LVEF \< 50%         0             0            ns
  Coronary disease    0             0            ns
  Diabetes mellitus   0             0            ns
  Medications         0             0            ns

Values are displayed as mean ± standard deviation.

LVEF: left ventricular ejection fraction.

###### 

Six overexpressed and 14 downregulated miRNAs in aortic tissue from AS patients compared to the control group.

  Systematic name    *p* value   FC (abs)   Regulation
  ------------------ ----------- ---------- ------------
  hsa-miR-193a-3p    0.020637    2.067236   Up
  hsa-miR-29b-1-5p   0.0222      11.56757   Up
  hsa-miR-505-5p     0.030211    13.22606   Up
  hsa-miR-194-5p     0.036807    14.95685   Up
  hsa-miR-99b-3p     0.029772    15.98001   Up
  hsa-miR-200b-3p    0.021638    20.1747    Up
  hsa-miR-3663-3p    0.042986    2.063909   Down
  hsa-miR-513a-5p    0.01703     2.238355   Down
  hsa-miR-146b-5p    0.040094    2.244855   Down
  hsa-miR-1972       0.033015    2.432029   Down
  hsa-miR-718        0.033461    2.559791   Down
  hsa-miR-3138       0.002648    2.69498    Down
  hsa-miR-21-5p      0.004216    3.334316   Down
  hsa-miR-630        0.020492    3.564175   Down
  hsa-miR-575        0.029949    5.137385   Down
  hsa-miR-301a-3p    0.011849    20.77046   Down
  hsa-miR-636        0.010177    25.1902    Down
  hsa-miR-34a-3p     0.013993    25.44595   Down
  hsa-miR-21-3p      0.02304     32.11932   Down
  hsa-miR-516a-5p    0.022169    41.76603   Down
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